88IV - Public company info - Aceso Life Science Group Limited

Input the stock code or the company name

Aceso Life Science Group Limited, 00474.HK - Cash Flow	2023-03	2022-03	2021-03	2020-03	2019-03	2018-03	2017-03	2016-03	2015-03	2014-03	2013-03	2012-03	2011-03	2010-03	2009-03	2008-03	2007-03	2006-03	2005-03
Net Cash Flow from Operating Activities	222,000	319,000	190,000	-355,355	-76,073	-66,076	571,768	-518,121	-1,456,889	-189,843	-66,381	-88,402	-60,815	29,666	19,341	40,054	22,769	26,243	17,955
Net Cash Flow from Return on Investments & Servicing of Finance	-111,000	-136,000	-103,000	-150,574	-95,570	-65,202	-44,099	-36,428	-33,368	-12,219	-11,869	297	-24	-3,821	-8,446	-4,536	-6,550	-17,068	-7,787
Interest Received	2,000	16,000	11,000	494	1,883	1,249	7,705	3,007	1,563	1,085	1,044	1,550	518	481	1,939	3,306	2,680	2,891	1,962
Interest Paid	-113,000	-152,000	-114,000	-152,000	-98,673	-67,231	-52,584	-42,277	-35,228	-13,601	-12,913	-1,253	-551	-121	-157	-47	-229	-216	-320
Dividend Received	0	0	0	932	1,220	780	780	2,842	297	297	0	0	9	847	59	2,346	999	257	571
Dividend Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	-5,028	-10,287	-10,141	-10,000	-20,000	-10,000
Others	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes (Paid) / Refunded	0	-3,000	-11,000	-961	-7,850	-18,391	-16,197	-8,298	-6,098	-3,913	-2,388	-4,611	-1,684	1,024	-3,274	-8,364	-4,476	-5,550	-3,136
Net Cash Flow from Investing Activities	-122,000	-457,000	-11,000	992,871	-1,250,510	-323,649	-627,639	-47,079	326,035	226,779	778,917	-120,063	-440,547	-169,938	-23,544	-26,903	-2,225	-5,844	-5,111
Additions to Fixed Assets	-47,000	-57,000	-15,000	-35,776	-68,015	-71,483	-24,101	-5,631	-15,468	-5,233	-91,915	-114,481	-190,547	-2,178	-770	-3,167	-665	-5,876	-1,277
Disposal of Fixed Assets	23,000	14,000	4,000	55,904	1,161	2,061	1,202	1,758	1,651	483	300	8,449	0	0	0	1,362	0	32	69
Increase in Investments	-508,000	-402,000	0	-608,511	-1,304,890	-275,202	-791,945	-25,000	-42,935	-688,439	-254,351	273	-3,988	-193,070	-20,474	-25,802	-1,560	0	-5,357
Decrease in Investments	27,000	4,000	0	1,582,007	108,980	130,192	75,806	43,557	378,407	964,581	1,404,442	561	11,977	19,993	3,017	704	0	0	0
Net Cash Flow with Related Parties	136,000	-11,000	218,000	-62,367	97,984	35,927	311,561	300,000	0	0	5,000	0	-49,685	-169,512	0	0	0	0	0
Others	247,000	-5,000	-218,000	61,614	-85,730	-145,144	-200,162	-361,763	4,380	-44,613	-284,559	-14,865	-208,304	174,829	-5,317	0	0	0	1,454
Net Cash Flow before Financing Activities	-11,000	-277,000	65,000	485,981	-1,430,003	-473,318	-116,167	-609,926	-1,170,320	20,804	698,279	-212,779	-503,070	-143,069	-15,923	251	9,518	-2,219	1,921
Net Cash Flow from Financing Activities	15,000	278,000	-261,000	-369,791	922,821	416,540	644,198	705,242	958,746	107,239	-458,020	207,818	248,898	390,306	-3,534	6,119	-780	-869	-425
New Loans	381,000	882,000	214,000	264,527	1,871,821	1,037,414	1,579,993	995,894	537,801	542,692	33,053	0	0	0	0	4,853	0	0	0
Loans Repayment	-520,000	-366,000	-303,000	-571,951	-666,878	-1,128,256	-1,414,268	-1,104,801	-179,000	-318,692	0	0	-9,080	0	-4,853	0	-780	-869	-425
Fixed Income/Debt Instruments	100,000	0	0	0	0	505,840	0	250,724	103,780	170,210	113,358	0	0	0	0	0	0	0	0
Repayment of Fixed Income/Debt Instruments	-73,000	-222,000	-390,000	0	-373,479	-155,308	-77,493	0	0	-293,715	-639,349	-317,000	0	0	0	0	0	0	0
Equity Financing	0	0	0	0	0	120,923	244,405	263,425	496,165	6,744	487	180,851	319,109	672,546	1,319	1,266	0	0	0
Net Cash Flow with Related Parties	136,000	-11,000	218,000	-62,367	97,984	35,927	311,561	300,000	0	0	5,000	0	-49,685	-169,512	0	0	0	0	0
Others	-9,000	-5,000	0	0	-6,627	0	0	0	0	0	29,431	343,967	-11,446	-112,728	0	0	0	0	0
Increase(Decrease) in Cash & Cash Equivalents	4,000	1,000	-196,000	116,190	-507,182	-56,778	528,031	95,316	-211,574	128,043	240,259	-4,961	-254,172	247,237	-19,457	6,370	8,738	-3,088	1,496
Cash & Cash Equivalents at Beginning of Year	195,000	198,000	382,000	267,040	781,431	816,372	295,782	203,575	416,322	287,262	46,971	48,676	302,671	54,659	75,564	64,476	54,675	58,190	56,691
Net Cash Flow due to Change in Exchange Rate/Others	-12,000	-4,000	12,000	-1,506	-7,209	21,837	-7,441	-3,109	-1,173	1,017	32	3,256	177	775	-1,448	4,718	1,063	-427	3
Cash & Cash Equivalents at End of Year	187,000	195,000	198,000	381,724	267,040	781,431	816,372	295,782	203,575	416,322	287,262	46,971	48,676	302,671	54,659	75,564	64,476	54,675	58,190
Currency	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar	Hong Kong Dollar
Unit	Thousand	Thousand	Thousand	Thousand	Thousand	Thousand	Thousand	Thousand
Auditor's Opinion	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

88iv | Home | Login

Mobile | Full

Suntek Computer Systems Limited.

Public company info - Aceso Life Science Group Limited , 00474.HK